- Home
- QFIN vs RXRX Comparison
QFIN vs RXRX Comparison
Compare QFIN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QFIN | RXRX |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | QFIN | RXRX |
|---|---|---|
| Price | $15.14 | $3.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $22.20 | $7.50 |
| AVG Volume (30 Days) | 2.1M | ★ 21.5M |
| Earning Date | 05-18-2026 | 05-06-2026 |
| Dividend Yield | ★ 12.36% | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | N/A | $12.11 |
| Revenue Next Year | N/A | $82.52 |
| P/E Ratio | $2.21 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $11.31 | $2.77 |
| 52 Week High | $46.18 | $7.18 |
Technical Indicators
Market Signals| Indicator | QFIN | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.69 | 47.53 |
| Support Level | $14.79 | $2.88 |
| Resistance Level | $15.46 | $4.01 |
| Average True Range (ATR) | 0.71 | 0.26 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 36.74 | 21.11 |
Price Performance
Historical ComparisonAbout QFIN Qifu Technology Inc.
Qfin Holdings Inc is engaged in matching individual borrowers with credit demand to a diversified pool of financial institutions with credit to supply through a financial technology platform. It has released large-scale financial credit multimodal benchmark, building a critical bridge between credit AI research and real-world applications.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.